FDA Unwilling To Change View On Dangers Of Zicam

By Julie Zeveloff (October 26, 2009, 1:41 PM EDT) -- The maker of Zicam, a cold medication that has come under fire in recent months for its potential danger to consumers, has said in a regulatory filing that the U.S. Food and Drug Administration is unwilling to reverse its stance that the medication could cause users to lose their sense of smell....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!